Therapeutic evaluation of sustained-releasing praziquantel (SRP) for clonorchiasis: Phase 1 and 2 clinical studies

Sustained-releasing praziquantel (SRP) tablet was designed for single dose treatment regimen of clonorchiasis. A previous pre-clinical study confirmed its sustained-releasing characteristics and a better cure rate than conventional praziquantel (PZQ). In this clinical study, the pharmacokinetics of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Choi, Min-Ho, Chang, Byung-Chan, Lee, Seung-Jin, Jang, In-Jin, Shin, Sang-Goo, Kho, Weon-Gyu, Chun, Jin-Ho, Hong, Sung-Tae
Format: Artigo
Jezik:Inglês
Izdano: The Korean Society for Parasitology 2006
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2559127/
https://ncbi.nlm.nih.gov/pubmed/17170578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3347/kjp.2006.44.4.361
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items